back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-08-09 16:27 Tx date 2019-08-06 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
+294,272 vol |
819,747 | |
| Filed 2019-07-03 00:21 Tx date 2019-06-27 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$120,888
+36,969 vol $3.27 each |
162,526 | |
| Filed 2019-06-19 15:31 Tx date 2019-06-17 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-294,272 vol |
525,475 | |
| Filed 2019-06-11 21:29 Tx date 2019-06-06 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-400,000 vol |
819,747 | |
| Filed 2019-06-11 21:27 Tx date 2019-06-06 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+694,272 vol |
1,219,747 | |
| Filed 2019-05-17 17:31 Tx date 2019-04-23 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
525,475 | |
| Filed 2019-05-17 17:27 Tx date 2019-02-05 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+125,475 vol |
125,475 | |
| Filed 2019-05-17 17:20 Tx date 2019-02-05 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+125,557 vol |
125,557 | |
| Filed 2019-05-17 17:14 Tx date 2019-02-05 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-17 17:13 Tx date 2019-02-05 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-17 17:10 Tx date 2019-02-05 |
$IAN
iAnthus Capital Holdings, Inc. |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-30 Tx date 2018-10-30 |
$MPX
MPX Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$121,500
+300,000 vol $0.405 each |
530,000 | |
| Filed 2018-03-01 Tx date 2017-10-30 |
$MPX
MPX Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-01 Tx date 2018-02-13 |
$MPX
MPX Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$80,500
+230,000 vol $0.35 each |
230,000 | |
| Filed 2018-01-16 Tx date 2018-01-15 |
$MPX
MPX Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$430,000
+500,000 vol $0.86 each |
750,000 | |
| Filed 2017-11-02 Tx date 2017-10-30 |
$MPX
The Canadian Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-02 Tx date 2017-10-30 |
$MPX
The Canadian Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$101,250
+250,000 vol $0.405 each |
250,000 | |
| Filed 2017-11-02 Tx date 2017-10-30 |
$MPX
The Canadian Bioceutical Corporation |
Galvin, Robert R.
4 - Director of Issuer
Holder: ARG Advisory Services LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,040,986 |